These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5922929)

  • 41. Ability of thyrocalcitonin to protect against hypercalcemia in adult rats.
    Harper C; Toverud SU
    Endocrinology; 1973 Dec; 93(6):1354-9. PubMed ID: 4752885
    [No Abstract]   [Full Text] [Related]  

  • 42. [Reduction of hypocalcemic and hypophosphatemic activity of calcitonin by propranolol in rats].
    Marnay-Gulat C; Labitte A
    C R Seances Soc Biol Fil; 1971 Jun; 165(11):2050-4. PubMed ID: 4262899
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the biological effectiveness of pharmaceutical parathyroid hormone preparations].
    Ziegler R; Lemmer B; Minne H; Pfeiffer EF
    Dtsch Med Wochenschr; 1966 Nov; 91(47):2114-7. PubMed ID: 5955978
    [No Abstract]   [Full Text] [Related]  

  • 44. Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate.
    Doppelt SH; Neer RM; Potts JT
    Calcif Tissue Int; 1981; 33(6):649-54. PubMed ID: 6459838
    [No Abstract]   [Full Text] [Related]  

  • 45. Hypercalcemia in acute uremia and following citric acid administration: differential effect on parathyroid gland microtubule content.
    Reaven GM; Reaven PD; Reaven EP
    Metabolism; 1976 Feb; 25(2):203-9. PubMed ID: 1250158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of salmon calcitonin on in vivo calcium absorption in rats.
    Cramer CF
    Calcif Tissue Res; 1973 Oct; 13(3):169-72. PubMed ID: 4792080
    [No Abstract]   [Full Text] [Related]  

  • 47. Receptor-adenylate cyclase components: abnormalities in clinical medicine.
    Aurbach GD
    Adv Cyclic Nucleotide Res; 1980; 12():1-9. PubMed ID: 6250344
    [No Abstract]   [Full Text] [Related]  

  • 48. Thyrocalcitonin: evidence for physiological function.
    Gray TKMUNSON PL
    Science; 1969 Oct; 166(3904):512-3. PubMed ID: 5821219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of acid-base disturbances on total plasma calcium and evidence for a homeostatic role of thyrocalcitonin.
    Irvin GL; Gittes RF; Gibbs MF
    Ann Surg; 1966 Dec; 164(6):1073-6. PubMed ID: 5926244
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of parathyroid hormone on ultrastructural and enzymatic changes induced by vitamin D in bone of thyroparathyroidectomized rats.
    Weisbrode SE; Capen CC; Nagode LA
    Lab Invest; 1974 Jun; 30(6):786-94. PubMed ID: 4275650
    [No Abstract]   [Full Text] [Related]  

  • 51. THYROID ORIGIN OF CALCITONIN.
    FOSTER GV; BAGHDIANTZ A; KUMAR MA; SLACK E; SOLIMAN HA; MACINTYRE I
    Nature; 1964 Jun; 202():1303-5. PubMed ID: 14210962
    [No Abstract]   [Full Text] [Related]  

  • 52. Fetal parathyroid gland and calcium homeostasis.
    Fleischman AR
    Clin Obstet Gynecol; 1980 Sep; 23(3):791-802. PubMed ID: 6998628
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of thyroparathyroidectomy: development of disuse osteoporosis in adult rats.
    Lindgren U
    Clin Orthop Relat Res; 1976; (118):251-6. PubMed ID: 954283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nicolas Andry award for 1973. Experimental osteopetrosis.
    Walker DG
    Clin Orthop Relat Res; 1973; (97):158-74. PubMed ID: 4590221
    [No Abstract]   [Full Text] [Related]  

  • 55. Parathyroid hormone and thyrocalcitonin function in cortisol-treated rats.
    Talmage RV; Park HZ; Jee W
    Endocrinology; 1970 May; 86(5):1080-4. PubMed ID: 5435249
    [No Abstract]   [Full Text] [Related]  

  • 56. PARATHYROID ORIGIN OF CALCITONIN--EVIDENCE FROM PERFUSION OF SHEEP GLANDS.
    COPP DH; HENZE KG
    Endocrinology; 1964 Jul; 75():49-55. PubMed ID: 14198296
    [No Abstract]   [Full Text] [Related]  

  • 57. Renal and systemic acid-base effects of the chronic administration of hypercalcemia-producing agents: calcitriol, PTH, and intravenous calcium.
    Hulter HN; Sebastian A; Toto RD; Bonner EL; Ilnicki LP
    Kidney Int; 1982 Mar; 21(3):445-58. PubMed ID: 6211566
    [No Abstract]   [Full Text] [Related]  

  • 58. The parafollicular cell of the thyroid gland as the source of an osteoblast-stimulating factor. Evidence from experimentally osteopetrotic mice.
    Marks SC
    J Bone Joint Surg Am; 1969 Jul; 51(5):875-90. PubMed ID: 5793848
    [No Abstract]   [Full Text] [Related]  

  • 59. Influence of the thyroids on the rate of removal of recently deposited radiocalcium and radiophosphorus from bone.
    Kennedy JW; Talmage RV
    Endocrinology; 1971 May; 88(5):1203-9. PubMed ID: 5547242
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of the thyroid gland during glucagon-induced hypocalcemia in the dog.
    Avioli LV; Birge SJ; Scott S; Shieber W
    Am J Physiol; 1969 Apr; 216(4):939-45. PubMed ID: 5775891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.